| Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study WK Seto, TSY Chan, YY Hwang, DKH Wong, J Fung, KSH Liu, H Gill, ... Journal of Clinical Oncology 32 (33), 3736-3743, 2014 | 366 | 2014 |
| Type II enteropathy‐associated T‐cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group E Tse, H Gill, F Loong, SJ Kim, SB Ng, T Tang, YH Ko, WJ Chng, ST Lim, ... American journal of hematology 87 (7), 663-668, 2012 | 182 | 2012 |
| Extranodal natural‐killer/t‐cell lymphoma, nasal type H Gill, RHS Liang, E Tse Advances in hematology 2010 (1), 627401, 2010 | 117 | 2010 |
| Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: a prospective study WK Seto, TSY Chan, YY Hwang, DKH Wong, J Fung, KSH Liu, H Gill, ... Hepatology 65 (5), 1451-1461, 2017 | 112 | 2017 |
| Association of hepatitis B core-related antigen with hepatitis B virus reactivation in occult viral carriers undergoing high-risk immunosuppressive therapy WK Seto, DKH Wong, TSY Chan, YY Hwang, J Fung, KSH Liu, H Gill, ... Official journal of the American College of Gastroenterology| ACG 111 (12 …, 2016 | 94 | 2016 |
| Disseminated infections with Talaromyces marneffei in non-AIDS patients given monoclonal antibodies against CD20 and kinase inhibitors JFW Chan, TSY Chan, H Gill, FYF Lam, NJ Trendell-Smith, S Sridhar, ... Emerging infectious diseases 21 (7), 1101, 2015 | 76 | 2015 |
| Molecular and cellular mechanisms of myelodysplastic syndrome: implications on targeted therapy H Gill, AYH Leung, YL Kwong International journal of molecular sciences 17 (4), 440, 2016 | 75 | 2016 |
| Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia SSY Lam, ESK Ho, BL He, WW Wong, CY Cher, NKL Ng, CH Man, H Gill, ... Science translational medicine 8 (359), 359ra129-359ra129, 2016 | 68 | 2016 |
| Long‐term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide‐based reinduction and maintenance regimens: A 15‐year prospective study H Gill, R Yim, HKK Lee, V Mak, SY Lin, B Kho, SF Yip, JSM Lau, W Li, ... Cancer 124 (11), 2316-2326, 2018 | 61 | 2018 |
| A novel tescalcin-sodium/hydrogen exchange axis underlying sorafenib resistance in FLT3-ITD+ AML CH Man, SSY Lam, MKH Sun, HCH Chow, H Gill, YL Kwong, AYH Leung Blood, The Journal of the American Society of Hematology 123 (16), 2530-2539, 2014 | 52 | 2014 |
| The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia. H Gill, GMK Leung, D Lopes, YL Kwong British journal of haematology 176 (6), 2017 | 44 | 2017 |
| From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag H Gill, RSM Wong, YL Kwong Therapeutic advances in hematology 8 (5), 159-174, 2017 | 41 | 2017 |
| Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome CY Cher, GMK Leung, CH Au, TL Chan, ESK Ma, JPY Sim, H Gill, ... Blood Cancer Journal 6 (7), e442-e442, 2016 | 39 | 2016 |
| Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting YY Hwang, H Gill, TSY Chan, GMK Leung, CYM Cheung, YL Kwong Hematology 23 (7), 399-404, 2018 | 36 | 2018 |
| Indolent T-cell large granular lymphocyte leukaemia after haematopoietic SCT: a clinicopathologic and molecular analysis H Gill, AHW Ip, R Leung, JCC So, AWK Pang, E Tse, AYH Leung, ... Bone marrow transplantation 47 (7), 952-956, 2012 | 36 | 2012 |
| Molecular targeted therapy and immunotherapy for myelodysplastic syndrome P Lee, R Yim, Y Yung, HT Chu, PK Yip, H Gill International Journal of Molecular Sciences 22 (19), 10232, 2021 | 30 | 2021 |
| Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study H Gill, Y Yung, HT Chu, WY Au, PK Yip, E Lee, R Yim, P Lee, D Cheuk, ... Blood Advances 5 (14), 2829-2838, 2021 | 30 | 2021 |
| Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis H Gill, HW Ip, R Yim, WF Tang, HH Pang, P Lee, GMK Leung, J Li, K Tang, ... Annals of Hematology 98, 869-879, 2019 | 29 | 2019 |
| SURPASS-ET: phase III study of ropeginterferon alfa-2b versus anagrelide as second-line therapy in essential thrombocythemia S Verstovsek, N Komatsu, H Gill, J Jin, SE Lee, HA Hou, T Sato, A Qin, ... Future Oncology 18 (27), 2999-3009, 2022 | 28 | 2022 |
| Autonomous motivation explains interprofessional education outcomes FA Ganotice Jr, H Gill, JTC Fung, JKT Wong, GL Tipoe Medical education 55 (6), 701-712, 2021 | 28 | 2021 |
Eric TseUniversity of Hong KongVerified email at hku.hk
